Ethyl 3-(2-furyl)acrylate
Common Name: |
Ethyl 3-(2-furyl)acrylate |
IUPAC Name: |
ethyl (E)-3-(furan-2-yl)prop-2-enoate |
Molecular Formula: |
C13H20O |
SMILES: |
CCOC(=O)C=CC1=CC=CO1 |
Inchi: |
1S/C9H10O3/c1-2-11-9(10)6-5-8-4-3-7-12-8/h3-7H,2H2,1H3/b6-5+ |
Inchi Key: |
MWZBTMXISMOMAE-AATRIKPKSA-N |
Cas No: |
623-20-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
192.30 |
Mass (g/mol) |
166.063 |
Molar Refractivity |
60.29 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
9.23 |
Hetero Atoms |
3 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
14 |
Boiling Point (°C@760.00mm Hg) |
229.00 to 231.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.06 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.69 |
LogP |
1.856 |
iLOGP |
2.96 |
XLOGP3 |
3.44 |
WLOGP |
3.82 |
MLOGP |
3.04 |
ESOL Log S |
-3.20 |
ESOL Solubility (mg/ml) |
0.121 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.31 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.15 |
Silicos-IT Solubility (mg/ml) |
0.14 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.03 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.574 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.961 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |